Ƶ

New GLP-1 Agonist Succeeds in Phase III; PFAS Chemicals & COVID-19

— News and commentary from the endocrinology world

Ƶ MedicalToday
ENDOBREAK centered between 8 illustrated body organs.

The highest dose of the once-weekly investigational helped people with type 2 diabetes achieve a 2.07% HbA1c reduction and an 11% drop in body weight in the 40-week phase III SURPASS program, Eli Lilly announced.

led to less efficient postprandial satiation and produced lower levels of appetite-regulating hormones than drinks sweetened with glucose. (The Journal of Clinical Endocrinology & Metabolism)

Preliminary research suggested that greater exposure to the -- and more specifically perfluorobutanoic acid (PFBA) found in drinking water -- may increase the risk of more severe COVID-19 illness. (The Intercept)

In related news, people with saw a nearly four times higher chance of hospitalization from COVID-19 and a 3.3-times higher odds for a more severe case. (Diabetes Care)

Following bariatric surgery, people who engaged in exercise had higher levels of in the lumbar spine than people who didn't. (Journal of Bone and Mineral Research)

When a , kids close by tended to gain weight. "We found that community food environment in urban neighborhoods matters for children's weight outcomes, especially as it relates to small stores located near children's homes," said study author Michael Yedidia, PhD, of Rutgers University in New Brunswick, New Jersey, in a statement. (Journal of the Academy of Nutrition and Dietetics)

applauded the Centers for Medicare & Medicaid Services on its 2021 Medicare Physician Fee Schedule final rule released last week.

Researchers at City of Hope in California announced they are recruiting trial participants to investigate a that uses the individual's own immune cells combined with a beta cell protein and vitamin D3.

  • author['full_name']

    Kristen Monaco is a senior staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.